Novel dosing strategies increase exposures of the potent antituberculosis drug rifapentine but are poorly tolerated in healthy volunteers.
about
A Phase 2 Randomized Trial of a Rifapentine plus Moxifloxacin-Based Regimen for Treatment of Pulmonary TuberculosisPhysiologically Based Pharmacokinetic Model of Rifapentine and 25-Desacetyl Rifapentine Disposition in Humans.Defining the optimal dose of rifapentine for pulmonary tuberculosis: Exposure-response relations from two phase II clinical trials.Rifapentine for the treatment of latent tuberculosis.Rifampin vs. rifapentine: what is the preferred rifamycin for tuberculosis?Pharmacokinetics of rifapentine and rifampin in a rabbit model of tuberculosis and correlation with clinical trial data.Mycobactericidal activity of bedaquiline plus rifabutin or rifampin in ex vivo whole blood cultures of healthy volunteers: A randomized controlled trial.
P2860
Q36012300-5A20BA5F-6B48-4B1D-B8F7-0B726483A78EQ37120003-CC7D3FA5-271F-41D6-B995-DC294E757149Q38851434-DE473F4D-ED36-4CB5-8E24-4AF51A3D9838Q38933165-2074BB95-C7BA-4F1E-9BCD-9D0D54FFAA87Q40095703-997BBD33-A56D-4749-B222-360F9621F9C5Q52606539-8CF4F01B-3FC3-4D66-8C0F-1BE9283583ABQ53687059-E32AEE2F-545A-487A-9811-A23B28EB18C8
P2860
Novel dosing strategies increase exposures of the potent antituberculosis drug rifapentine but are poorly tolerated in healthy volunteers.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Novel dosing strategies increa ...... lerated in healthy volunteers.
@ast
Novel dosing strategies increa ...... lerated in healthy volunteers.
@en
type
label
Novel dosing strategies increa ...... lerated in healthy volunteers.
@ast
Novel dosing strategies increa ...... lerated in healthy volunteers.
@en
prefLabel
Novel dosing strategies increa ...... lerated in healthy volunteers.
@ast
Novel dosing strategies increa ...... lerated in healthy volunteers.
@en
P2093
P2860
P356
P1476
Novel dosing strategies increa ...... lerated in healthy volunteers.
@en
P2093
ACTG A5311 Study Team
Constance A Benson
David W Haas
Evelyn Hogg
Jennifer Janik
Jeong-Gun Park
Kelly E Dooley
Kristine Patterson
Laura Hovind
Mark A Marzinke
P2860
P304
P356
10.1128/AAC.05128-14
P407
P577
2015-03-30T00:00:00Z